0,971  0,001  Pneumotoxic
0,946  0,002  Muscle relaxant
0,944  0,002  Skeletal muscle relaxant
0,881  0,002  Cardiodepressant
0,877  0,003  Spasmolytic
0,833  0,005  Antileukemic
0,796  0,003  Antiseptic
0,791  0,005  Prostate cancer treatment
0,754  0,023  Apoptosis agonist
0,739  0,015  Antineoplastic (breast cancer)
0,721  0,003  Anesthetic general
0,724  0,018  Transcription factor NF kappa B inhibitor
0,709  0,005  Vasodilator, peripheral
0,648  0,007  Histamine release inhibitor
0,656  0,023  Antineoplastic (lung cancer)
0,599  0,003  Dopamine D1 antagonist
0,595  0,003  Acetylcholine nicotinic antagonist
0,594  0,015  5 Hydroxytryptamine release stimulant
0,547  0,006  P-glycoprotein inhibitor
0,554  0,017  CYP2D6 substrate
0,550  0,023  Respiratory analeptic
0,538  0,017  Cardioprotectant
0,526  0,007  Antineoplastic (liver cancer)
0,520  0,008  Sigma receptor agonist
0,530  0,020  Radioprotector
0,510  0,014  Antipyretic
0,497  0,005  Toxic, respiratory center
0,490  0,011  Sedative
0,507  0,047  Analgesic
0,435  0,004  Opioid kappa receptor antagonist
0,448  0,016  Vasodilator
0,458  0,028  Caspase 3 stimulant
0,434  0,007  Dopamine antagonist
0,442  0,029  Antineoplastic (pancreatic cancer)
0,410  0,004  Neuronal nicotinic receptor antagonist
0,412  0,007  Cholinergic antagonist
0,412  0,007  Acetylcholine antagonist
0,441  0,043  CYP2C19 inhibitor
0,394  0,003  Nicotinic receptor alpha3 subunit antagonist
0,414  0,026  Free radical scavenger
0,392  0,005  Analgesic, opioid
0,394  0,007  Dopamine D2 antagonist
0,391  0,005  Opioid antagonist
0,407  0,026  Tumour necrosis factor alpha release inhibitor
0,392  0,011  DNA methylase inhibitor
0,406  0,029  Hypoxia-inducible factor 1 alpha inhibitor
0,378  0,003  Calcium antagonist
0,432  0,063  Antiparkinsonian
0,372  0,004  Opioid mu receptor antagonist
0,407  0,041  Hepatic disorders treatment
0,369  0,005  Dopamine agonist
0,399  0,041  CYP2C19 substrate
0,383  0,026  Antimitotic
0,385  0,041  Analeptic
0,398  0,063  CYP3A4 substrate
0,419  0,084  Alzheimer's disease treatment
0,360  0,030  Psychostimulant
0,386  0,056  Antineoplastic (colorectal cancer)
0,330  0,007  Alpha 2 adrenoreceptor antagonist
0,331  0,016  Tubulin antagonist
0,331  0,018  Antineoplastic (squamous cell carcinoma)
0,333  0,020  UGT2B7 substrate
0,367  0,057  Antineoplastic (colon cancer)
0,315  0,004  Opioid agonist
0,332  0,030  Antineoplastic enhancer
0,297  0,005  Constipation treatment
0,292  0,004  Opioid mu receptor agonist
0,357  0,069  Antiprotozoal (Plasmodium)
0,313  0,027  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,398  0,112  Caspase 9 stimulant
0,289  0,005  Opioid delta receptor antagonist
0,286  0,004  Dopamine D2 agonist
0,331  0,051  UGT1A9 substrate
0,331  0,052  Antioxidant
0,337  0,061  Antineoplastic (ovarian cancer)
0,314  0,052  DNA damaging
0,323  0,069  AR expression inhibitor
0,339  0,085  CYP2C9 substrate
0,267  0,018  Alpha adrenoreceptor antagonist
0,316  0,068  Antineoplastic (brain cancer)
0,281  0,035  Hepatoprotectant
0,308  0,065  CYP1A2 substrate
0,282  0,039  UDP-glucuronosyltransferase substrate
0,259  0,018  UGT2B9 substrate
0,266  0,027  UGT1A3 substrate
0,248  0,009  Alpha 2a adrenoreceptor antagonist
0,242  0,005  Electron transport complex I inhibitor
0,238  0,004  Opioid kappa receptor agonist
0,248  0,015  Antitussive
0,236  0,004  Dopamine D5 antagonist
0,277  0,046  Tyrosine 3 hydroxylase inhibitor
0,250  0,021  LDLR expression enhancer
0,244  0,021  Antidiarrheal
0,305  0,082  Apoptosis antagonist
0,334  0,112  Antibacterial
0,271  0,051  Dependence treatment
0,321  0,101  Antineoplastic (myeloid leukemia)
0,226  0,011  Polo-like kinase-4 inhibitor
0,233  0,019  Antiadrenergic
0,256  0,044  Antiviral (Influenza)
0,242  0,030  Anesthetic
0,216  0,005  Histamine N-methyltransferase inhibitor
0,268  0,056  5 Hydroxytryptamine 1E antagonist
0,253  0,043  Antialcoholic
0,234  0,027  5 Hydroxytryptamine antagonist
0,283  0,077  Antineoplastic (melanoma)
0,223  0,020  Adrenaline antagonist
0,206  0,003  Antibiotic Glycopeptide-like
0,246  0,049  UGT1A1 substrate
0,274  0,078  Antihypoxic
0,229  0,035  Cholinergic
0,234  0,045  Male reproductive disfunction treatment
0,205  0,017  Alpha 2c adrenoreceptor antagonist
0,242  0,054  Nitric oxide antagonist
0,221  0,034  Antiviral (Influenza A)
0,215  0,029  Acetylcholinesterase inhibitor
0,256  0,072  Antineoplastic (glioma)
0,304  0,121  Antiprotozoal
0,187  0,005  Nicotinic receptor alpha7 subunit antagonist
0,199  0,019  Antiprotozoal (Amoeba)
0,237  0,059  Antiarrhythmic
0,199  0,022  Butyrylcholinesterase inhibitor
0,184  0,009  Sigma receptor antagonist
0,188  0,015  Breast cancer-resistant protein inhibitor
0,185  0,014  Antiviral (Influenza B)
0,184  0,015  Uric acid excretion stimulant
0,232  0,070  Antihypotensive
0,193  0,033  Cocaine dependence treatment
0,162  0,005  Narcotic antagonist
0,189  0,036  Antinephritic
0,163  0,015  Toll-Like receptor 4 antagonist
0,165  0,020  AMP-activated protein kinase stimulant
0,160  0,018  Prolactin inhibitor
0,206  0,066  Mutagenic
0,226  0,086  Antineoplastic (cervical cancer)
0,224  0,086  NOS2 expression inhibitor
0,172  0,033  5 Hydroxytryptamine 2B antagonist
0,187  0,049  Antineoplastic (carcinoma)
0,169  0,032  Alpha 2b adrenoreceptor antagonist
0,208  0,074  Amyloid beta aggregation inhibitor
0,134  0,005  Opioid delta receptor agonist
0,218  0,089  Antiprotozoal (Leishmania)
0,154  0,026  Antineoplastic alkaloid
0,155  0,028  Alpha 1 adrenoreceptor antagonist
0,129  0,003  Prolactin release inhibitor
0,132  0,018  Tocolytic
0,133  0,021  Phosphodiesterase I inhibitor
0,223  0,112  5 Hydroxytryptamine uptake stimulant
0,121  0,016  Calcium channel L-type blocker
0,243  0,141  Vasodilator, coronary
0,149  0,047  Alkylator
0,193  0,093  Antiparkinsonian, rigidity relieving
0,225  0,126  CYP2D6 inhibitor
0,165  0,067  Uterine stimulant
0,210  0,111  Antineoplastic (sarcoma)
0,156  0,059  Erectile dysfunction treatment
0,102  0,006  Potassium channel small-conductance Ca-activated blocker
0,158  0,063  Lipid peroxidase inhibitor
0,131  0,037  Multidrug resistance-associated protein 1 inhibitor
0,104  0,012  Uterine relaxant
0,120  0,029  Alpha 1a adrenoreceptor antagonist
0,201  0,112  Hypoglycemic
0,180  0,092  VEGF expression inhibitor
0,117  0,031  5 Hydroxytryptamine 1 antagonist
0,113  0,028  5 Hydroxytryptamine 1A antagonist
0,127  0,042  UGT2B1 substrate
0,134  0,054  Acetylcholine muscarinic antagonist
0,104  0,024  5 Hydroxytryptamine 7 antagonist
0,085  0,012  Nicotinic receptor alpha4 subunit antagonist
0,115  0,042  Antihypermotility
0,102  0,030  5 Hydroxytryptamine 1F antagonist
0,076  0,004  Liver X receptor alpha antagonist
0,110  0,040  Protein kinase C zeta inhibitor
0,163  0,094  Sensitization
0,083  0,015  Phosphodiesterase 1A inhibitor
0,093  0,027  Dopamine D3 antagonist
0,082  0,017  Potassium channel (Ca-activated) blocker
0,069  0,006  Liver X receptor antagonist
0,098  0,037  Antiprotozoal activity enhancer
0,203  0,142  Antidepressant
0,136  0,078  Protein kinase stimulant
0,203  0,147  NOS3 expression inhibitor
0,121  0,066  Topoisomerase II inhibitor
0,057  0,004  Dopamine D1 agonist
0,099  0,046  5 Hydroxytryptamine 2C antagonist
0,107  0,054  Dementia treatment
0,114  0,063  5 Hydroxytryptamine 2 antagonist
0,150  0,099  Carcinogenic
0,103  0,054  Vascular dementia treatment
0,131  0,082  Antiparkinsonian, tremor relieving
0,203  0,154  Nootropic
0,209  0,162  CYP3A4 inhibitor
0,068  0,021  5 Hydroxytryptamine 7 agonist
0,072  0,028  5 Hydroxytryptamine 6 antagonist
0,067  0,026  Alpha tubulin antagonist
0,123  0,081  Skin whitener
0,065  0,025  Ryanodine receptor antagonist
0,104  0,064  Expectorant
0,132  0,093  Acetylcholine M1 receptor antagonist
0,196  0,157  12-Lipoxygenase inhibitor
0,069  0,031  Dopamine uptake inhibitor
0,057  0,021  Factor III inhibitor
0,070  0,034  Beta tubulin antagonist
0,071  0,036  Dopamine D4 antagonist
0,070  0,036  5 Hydroxytryptamine 2A agonist
0,212  0,180  Stroke treatment
0,119  0,087  Antihemorrhagic
0,091  0,060  Restless leg syndrome treatment
0,086  0,055  5 Hydroxytryptamine 2A antagonist
0,048  0,019  Dopamine D5 agonist
0,098  0,069  Nav1.1 sodium channel blocker
0,143  0,115  UGT2B10 substrate
0,097  0,070  Estrogen receptor beta antagonist
0,252  0,225  5 Hydroxytryptamine release inhibitor
0,092  0,065  Antischistosomal
0,155  0,131  Neurotrophic factor enhancer
0,143  0,120  Septic shock treatment
0,114  0,094  Antihelmintic (Trematoda)
0,092  0,073  Bronchodilator
0,050  0,032  Dopamine transporter inhibitor
0,113  0,097  Antimutagenic
0,156  0,140  Antiamyloidogenic
0,152  0,137  Aldehyde oxidase inhibitor
0,104  0,090  Estrogen antagonist
0,078  0,064  Phosphodiesterase XI inhibitor
0,078  0,064  Phosphodiesterase 11A inhibitor
0,120  0,107  Antidote
0,141  0,129  Antineoplastic (glioblastoma multiforme)
0,038  0,027  Vesicle monoamine transporter inhibitor
0,118  0,108  Chemopreventive
0,120  0,110  Genotoxic
0,042  0,033  Liver X receptor agonist
0,154  0,148  Antineoplastic (non-small cell lung cancer)
0,042  0,036  5 Hydroxytryptamine 1A agonist
0,014  0,012  NMDA receptor phencyclidine site antagonist
0,110  0,108  UGT2B15 substrate
0,061  0,060  Alpha 1b adrenoreceptor antagonist

